1. Home
  2. CSBR vs TSE Comparison

CSBR vs TSE Comparison

Compare CSBR & TSE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CSBR
  • TSE
  • Stock Information
  • Founded
  • CSBR 1985
  • TSE 2010
  • Country
  • CSBR United States
  • TSE United States
  • Employees
  • CSBR N/A
  • TSE N/A
  • Industry
  • CSBR Biotechnology: Biological Products (No Diagnostic Substances)
  • TSE Major Chemicals
  • Sector
  • CSBR Health Care
  • TSE Industrials
  • Exchange
  • CSBR Nasdaq
  • TSE Nasdaq
  • Market Cap
  • CSBR 113.0M
  • TSE 151.9M
  • IPO Year
  • CSBR 1986
  • TSE 2014
  • Fundamental
  • Price
  • CSBR $7.33
  • TSE $3.85
  • Analyst Decision
  • CSBR Strong Buy
  • TSE
  • Analyst Count
  • CSBR 1
  • TSE 0
  • Target Price
  • CSBR $12.00
  • TSE N/A
  • AVG Volume (30 Days)
  • CSBR 37.5K
  • TSE 283.5K
  • Earning Date
  • CSBR 03-11-2025
  • TSE 05-07-2025
  • Dividend Yield
  • CSBR N/A
  • TSE 1.01%
  • EPS Growth
  • CSBR N/A
  • TSE N/A
  • EPS
  • CSBR 0.46
  • TSE N/A
  • Revenue
  • CSBR $58,591,000.00
  • TSE $3,513,200,000.00
  • Revenue This Year
  • CSBR $15.11
  • TSE $5.72
  • Revenue Next Year
  • CSBR $7.80
  • TSE $3.80
  • P/E Ratio
  • CSBR $16.53
  • TSE N/A
  • Revenue Growth
  • CSBR 19.03
  • TSE N/A
  • 52 Week Low
  • CSBR $3.60
  • TSE $1.94
  • 52 Week High
  • CSBR $11.99
  • TSE $7.05
  • Technical
  • Relative Strength Index (RSI)
  • CSBR 41.18
  • TSE 49.34
  • Support Level
  • CSBR $7.21
  • TSE $3.05
  • Resistance Level
  • CSBR $8.27
  • TSE $4.13
  • Average True Range (ATR)
  • CSBR 0.66
  • TSE 0.21
  • MACD
  • CSBR 0.01
  • TSE 0.11
  • Stochastic Oscillator
  • CSBR 17.13
  • TSE 63.60

About CSBR Champions Oncology Inc.

Champions Oncology Inc is a USA based company which is engaged in the development and sale of state of the art technology solutions and products to personalize the development and use of oncology drugs. The company operates through one segment namely Personalized Oncology Solutions (POS) and Translational Oncology Solutions (TOS). Its POS business assists physicians in developing personalized treatment options for their cancer patients through tumor-specific data obtained from drug panels and related personalized oncology services. The TOS business assists pharmaceutical and biotechnology companies with their drug development process and offers studies or license tumors for use in studies. The company's revenue is majorly derived from research services.

About TSE Trinseo PLC

Trinseo PLC is a materials company and manufacturer of latex and plastics products. The company's operating segments include Latex Binders, Americas Styrenics, Engineered Materials, and Polymer Solutions. Maximum revenue is generated from its Polymer Solutions segment, which consists of various polymers, the majority of which are for automotive, building, and construction applications. The product offerings of this segment include ABS, styrene-acrylonitrile, polystyrene, and polycarbonate products, which are marketed through brands like Magnum and Styron. Geographically, the company generates maximum revenue from Europe, followed by the United States, Asia-Pacific, and the Rest of the world.

Share on Social Networks: